Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen.

Zhang, Xiang; Li, Jianhu; Jin, Jie; Yu, Wenjuan

Zhang, Xiang; Li, Jianhu; Jin, Jie; Yu, Wenjuan.

Affiliation

Zhang X; Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, 310003, Zhejiang, China.
Li J; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Jin J; Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, Hangzhou, Zhejiang, China.
Yu W; Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, 310003, Zhejiang, China.

Ann Hematol ; 99(2): 395-397, 2020 Feb.

Article in En | MEDLINE | ID: mdl-31879788

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Salvage Therapy; Aclarubicin/administration & dosage; Aclarubicin/analogs & derivatives; Adult; Antigens, Neoplasm/analysis; Bridged Bicyclo Compounds, Heterocyclic/administration & dosage; Combined Modality Therapy; Cytarabine/administration & dosage; Granulocyte Colony-Stimulating Factor/administration & dosage; Hematopoietic Stem Cell Transplantation; Homoharringtonine/administration & dosage; Humans; Male; Mutation; Neoplasm Proteins/genetics; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/therapy; Recurrence; Remission Induction; Sulfonamides/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Limits: Adult / Humans / Male Language: En Journal: Ann Hematol Year: 2020 Document type: Article

Fulltext

XML

PubMed Links

Search on Google